Test homogeneity of Odds ratio in a randomized clinical trial with noncompliance

Journal of Biopharmaceutical Statistics

Volumn 19, Issue 5, 2009, Pages 916-932

  Lui, Kung Jong ^a   Chang, Kuang Chao ^b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Homogeneity; ITT analysis; Meta analysis; Noncompliance; Odds ratio

Indexed keywords

ARTICLE; INTENT TO TREAT ANALYSIS; MEASUREMENT ERROR; META ANALYSIS; MONTE CARLO METHOD; PATIENT COMPLIANCE; POISSON DISTRIBUTION; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK; SMOKING CESSATION; TREATMENT NONCOMPLIANCE; TREATMENT RESPONSE;

ADULT; BIAS (EPIDEMIOLOGY); COMPUTER SIMULATION; CORONARY DISEASE; DATA INTERPRETATION, STATISTICAL; HUMANS; LEAST-SQUARES ANALYSIS; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; MODELS, STATISTICAL; MONTE CARLO METHOD; MULTICENTER STUDIES AS TOPIC; ODDS RATIO; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 75149157972     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400903105497     Document Type: Article

References (37)

1. Angrist, J. D., Imbens, G. W., Rubin, D. B. (1996). Identification of causal effects using instrumental variables. J. Am. Stat. Assoc. 91:444-456.
2. Agresti, A. (1990). Categorical Data Analysis. New York: Wiley.
3. Breslow, N. E., Day, N. E. (1980). Statistical methods in cancer research. The Analysis of Case-Control Studies. Vol.1. Lyon: International Agency for Research on Cancer.
4. Brunner, E., Neumann, N. (1985). On the mathematical basis of Zelen's prerandomized designs. Methods Information Med. 24:120-130.
5. Casella, G., Berger, R. L. (1990). Statistical Inference. Belmont, CA: Duxbury.
6. Cornfield, J. A. (1956). Statistical problem arising from retrospective studies. In: Neyman, J. ed. Proc. Third Berkeley Symp. Math. Stat. Prob, Vol.4. Berkeley: University of California Press, pp. 135-148.
7. Fisher, R. A. (1924). On a distribution yielding the error functions of several well known statistics. Proc. Int. Math. Congr. 2:805-813.
8. Fleiss, J. L. (1981). Statistical Methods for Rates and Proportions. 2nd ed. New York: Wiley.
9. Fleiss, J. L. (1986). The Design and Analysis of Clinical Experiments. New York: Wiley.
10. Frangakis, C. E., Rubin, D. B. (1999). Addressing complications of intention-to-treat analysis in the combined presence of all-or-none treatment-noncompliance and subsequent missing outcomes. Biometrika 86:365-379.
11. Garrett, A. D. (2003). Therapeutic equivalence: Fallacies and falsification. Stat. Med. 22:741-762.
12. Jacobson, J. M., Spritzler, J., Fox, L., Fahley, J. L., Jackson, J. B., Chernoff, M., Wohl, D. A., Wu, A. W., Hooton, T. M., Sha, B. E., Shikuma, C. M., MacPhail, L. A., Simpson, D. M., Trapnell, C. B., Basgoz, N. (1999). Thalidomide for the treatment of esophageal aphthour ulcers in patients with human immunodeficiency virus infection. J. Infect. Dis. 180:61-67.
13. Last, J. M. (1988). A Dictionary of Epidemiology. 2nd ed. Oxford: Oxford University Press.
14. Li, F., Frangakis, C. E. (2005). Designs in partially controlled studies. Message from a review. Stat. Methods Med. Res. 14:417-431.
15. Lipsitz, S. R., Dear, K. B. G., Laird, N. M., Molengberghs, G. (1998). Tests for homogeneity of the risk difference when data are sparse. Biometrics 54:148-160.
16. Liu, J. P., Fan, H.-Y., Ma, M.-C. (2005). Tests for equivalence based on odds ratio for matched-pair design. J. Biopharm. Stat. 15:889-901.
17. Lui, K.-J. (2004). Statistical Estimation of Epidemiological Risk. New York: Wiley.
18. Lui, K.-J. (2007a). Interval estimation of the risk difference in non-compliance randomized trials with repeated binary measurements. Stat. Med. 26:3140-3156.
19. Lui, K.-J. (2007b). Estimation of proportion ratio in non-compliance randomized trials with repeated measurements in binary data. Stat. Methodol. 5:129-141.
20. Lui, K.-J. (2007c). Testing homogeneity of the risk ratio in stratified noncompliance randomized trials. Contemp. Clin. Trials 28:614-625.
21. Lui, K.-J., Kelly, C. (2000a). A revisit on tests for homogeneity of the risk difference. Biometrics 56:309-315. (Pubitemid 30165126)
22. Lui, K.-J., Kelly, C. (2000b). Tests for homogeneity of the risk ratio in a series of 2 × 2 tables. Stat. Med. 19:2919-2932. (Pubitemid 30828015)
23. Lui, K.-J., Chang, K.-C. (2008). Testing homogeneity of risk difference in stratified randomized trials with noncompliance. Comput. Stat. Data Anal. 53:209-221.
24. Mark, S. D., Robins, J. M. (1993). A method for the analysis of randomized trials with compliance information: An application to the multiple risk factor intervention trial. Control. Clin. Trials 14:79-97.
25. Matsui, S. (2005). Stratified analysis in randomized trials with noncompliance. Biometrics 61:816-823.
26. Multiple Risk Factor Intervention Trial Research Group (1982). Multiple risk factor intervention trial: Risk factor changes and mortality results. J. Am. Med. Assoc. 248:1465-1477.
27. Nagelkerke, N., Fidler, V., Bernsen, R., Borgdorff, M. (2000). Estimating treatment effects in randomized clinical trials in the presence of non-compliance. Stat. Med. 19:1849-1864.
28. Rubin, D. B. (1978). Bayesian interface for causal effects: The role of randomization. Ann. Stat. 6:34-58.
29. Rousson, V., Seifert, B. (2008). A mixed approach for proving non-inferiority in clinical trials with binary endpoints. Biometrical J. 50:190-204.
30. SAS Institute Inc (1990). SAS Language, Reference Version 6. 1st ed. Cary, NC: SAS Institute Inc.
31. Sommer, A., Zeger, S. L. (1991). On estimating efficacy from clinical trials. Stat. Med. 10:45-52.
32. Tu, D. (1998). On the use of the ratio or the odds ratio of cure rates in establishing therapeutic equivalence of non-systemic drugs with binary clinical endpoints. J. Biopharm. Stat. 8:263-282.
33. Tu, D. (2003). Odds ratio. In: Chow, S. C., ed. Encyclopedia of Biopharmaceutical Statistics. New York: Taylor & Francis.
34. Wang, H., Chow, S.-C., Li, G. (2002). On sample size calculation based on odds ratio in clinical trials. J. Biopharm. Stat. 12:471-483. (Pubitemid 35439795)
35. Whitehead, A., Bailey, A. J., Elbourne, D. (1999). Combining summaries of binary outcomes with those of continuous outcomes in a meta-analysis. J. Biopharm. Stat. 9:1-16.
36. Zelen, M. (1990). Randomized consent designs for clinical trials: An update. Stat. Med. 9:645-656.
37. Zhou, X.-H., Li, S. M. (2006). ITT analysis of randomized encouragement design studies with missing data. Stat. Med. 25:2737-2761.